G
Gao Qi
Publications - 6
Citations - 386
Gao Qi is an academic researcher. The author has contributed to research in topics: Plasmodium vivax & Public health. The author has an hindex of 5, co-authored 6 publications receiving 357 citations.
Papers
More filters
Journal ArticleDOI
Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group
Nicholas M. Anstey,Sarah Auburn,J K Baird,Katherine E. Battle,A Bobogare,Arna Chancellor,S Chasombat,Qin Cheng,Gonzalo J. Domingo,Chris Drakeley,Tobgyel Drukpa,Lek Dysoley,F Esperanza Espino,Peter W. Gething,Prakash Ghimire,Roly Gosling,P Grewal-Daumerie,Si Hay,Rosalind E. Howes,Jimee Hwang,J Karim,Wasif A. Khan,J-Y Kim,Benedikt Ley,Kylie Mannion,James S. McCarthy,WM Keong,Ivo Mueller,Rinzin Namgay,Ric N. Price,Gao Qi,M Rebueno,John C. Reeder,Jack S. Richards,J Sattabongkot-Prachumsri,GD Shanks,Carol Hopkins Sibley,Asik Surya,George Taleo,ND Thang,Thongpaseuth,Kamala Thriemer,Hidayat Trimarsanto,Lasse S Vestergaard,L von Seidelein,Maxine Whittaker,VW Grp +46 more
TL;DR: The issues faced and the solutions found in developing this robust strategic partnership between national programmes and research partners within the APMEN Vivax Working Group are described.
Journal ArticleDOI
Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.
Kamala Thriemer,Albino Bobogare,Benedikt Ley,Clarice Samo Gudo,Mohammad Shafiul Alam,Nicholas M. Anstey,Elizabeth A. Ashley,J. Kevin Baird,Charlotte Gryseels,Elodie Jambert,Marcus V. G. Lacerda,Ferdinand Laihad,Jutta Marfurt,Ayodhia Pitaloka Pasaribu,Jeanne Rini Poespoprodjo,Inge Sutanto,Walter R. J. Taylor,Christel van den Boogaard,Katherine E. Battle,Lek Dysoley,Prakash Ghimire,Bill Hawley,Jimee Hwang,Jimee Hwang,Wasif A. Khan,Rose Nani Mudin,Maria Endang Sumiwi,Rukhsana Ahmed,M. M. Aktaruzzaman,Kiran Raj Awasthi,Azucena Bardají,Derek Bell,Leonard Boaz,Faustina Helen Burdam,Daniel Chandramohan,Qin Cheng,Keobouphaphone Chindawongsa,Janice Culpepper,Santasabuj Das,Raffy Deray,Meghna Desai,Gonzalo J. Domingo,Wang Duoquan,Stephan Duparc,Rustini Floranita,Emily Gerth-Guyette,Rosalind E. Howes,Cecilia Hugo,George Jagoe,Elvieda Sariwati,Sanya Tahmina Jhora,Wu Jinwei,Harin Karunajeewa,Enny Kenangalem,Bibek Kumar Lal,Chandra Umbu Reku Landuwulang,Emmanuel Le Perru,Sang-Eun Lee,Leo Makita,James S. McCarthy,Asrat Hailu Mekuria,Neelima Mishra,Esau Naket,Simone Nambanya,Johnny Nausien,Thang Ngo Duc,Thuan Nguyen Thi,Rinitis Noviyanti,Daniel A. Pfeffer,Daniel A. Pfeffer,Gao Qi,Annisa Rahmalia,Annisa Rahmalia,Stephen J. Rogerson,Iriani Samad,Jetsumon Sattabongkot,Ari W. Satyagraha,Dennis Shanks,Surender Nath Sharma,Carol Hopkins Sibley,Ali Sungkar,Din Syafruddin,Arunansu Talukdar,Joel Tarning,Feiko O. ter Kuile,Feiko O. ter Kuile,Suman Thapa,Minerva Theodora,Tho Tran Huy,Edward Waramin,Govert Waramori,Adugna Woyessa,Chansuda Wongsrichanalai,Nguyen Xuan Xa,Joon Sup Yeom,Lukas Hermawan,Angela Devine,Angela Devine,Spike Nowak,Indra Jaya,Supargiyono Supargiyono,Koen Peeters Grietens,Ric N. Price,Ric N. Price +103 more
TL;DR: Reaching the elimination goal will require innovative approaches to improve radical cure for vivax malaria, as well as the methods to evaluate its effectiveness.
Journal ArticleDOI
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group.
Kamala Thriemer,Benedikt Ley,Albino Bobogare,Lek Dysoley,Mohammad Shafiul Alam,Ayodhia Pitaloka Pasaribu,Jetsumon Sattabongkot,Elodie Jambert,Gonzalo J. Domingo,Robert J. Commons,Sarah Auburn,Jutta Marfurt,Angela Devine,Angela Devine,Mohammad M. Aktaruzzaman,Nayeem Sohel,Rinzin Namgay,Tobgyel Drukpa,Surender Nath Sharma,Elvieda Sarawati,Iriani Samad,Minerva Theodora,Simone Nambanya,Sonesay Ounekham,Rose Nanti Binti Mudin,Garib Da Thakur,Leo Makita,Raffy Deray,Sang-Eun Lee,Leonard Boaz,Manjula N. Danansuriya,Santha D. Mudiyanselage,Nipon Chinanonwait,Suravadee Kitchakarn,Johnny Nausien,Esau Naket,Thang Ngo Duc,Ha Do Manh,Young S. Hong,Qin Cheng,Jack S. Richards,Rita Kusriastuti,Ari W. Satyagraha,Rintis Noviyanti,Xavier C. Ding,Wasif A. Khan,Ching Swe Phru,Zhu Guoding,Gao Qi,Akira Kaneko,Akira Kaneko,Olivo Miotto,Olivo Miotto,Olivo Miotto,Wang Nguitragool,Wanlapa Roobsoong,Katherine E. Battle,Rosalind E. Howes,Arantxa Roca-Feltrer,Stephan Duparc,Ipsita Pal Bhowmick,Enny Kenangalem,Jo-Anne Bibit,Alyssa E. Barry,Alyssa E. Barry,David Sintasath,Rabindra R Abeyasinghe,Carol Hopkins Sibley,James S. McCarthy,Lorenz von Seidlein,J. Kevin Baird,Ric N. Price,Ric N. Price +72 more
TL;DR: Robust strategies are needed to ensure that effective treatment practices can be deployed widely, and these should ensure that the caveats are outweighed by the benefits of radical cure for both the patients and the community.
Journal ArticleDOI
Barriers to routine G6PD testing prior to treatment with primaquine
Benedikt Ley,Kamala Thriemer,Jessica Jaswal,Eugenie Poirot,Mohammad Shafiul Alam,Ching Swe Phru,Wasif A. Khan,Lek Dysoley,Gao Qi,Chong Chee Kheong,Ummi Kalthom Shamsudin,Ingrid Chen,Jimee Hwang,Jimee Hwang,Roly Gosling,Ric N. Price,Ric N. Price +16 more
TL;DR: Greater efforts are needed to increase awareness of the benefits of the radical cure of Plasmodium vivax and this should be supported by economic analyses exploring the cost effectiveness of routine G6PD testing.
Journal ArticleDOI
Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity
Jin-Hee Han,Jin-Hee Han,Jee Sun Cho,Jessica Jie Ying Ong,Ji-Hoon Park,Myat Htut Nyunt,Edwin Sutanto,Hidayat Trimarsanto,Beyene Petros,Abraham Aseffa,Sisay Getachew,Kanlaya Sriprawat,Nicholas M. Anstey,Matthew J. Grigg,Bridget E. Barber,Timothy William,Gao Qi,Yaobao Liu,Richard D. Pearson,Richard D. Pearson,Sarah Auburn,Sarah Auburn,Sarah Auburn,Ric N. Price,Ric N. Price,Ric N. Price,François Nosten,François Nosten,Laurent Rénia,Bruce Russell,Eun-Taek Han +30 more
TL;DR: Results suggest that PvEBP-RII is mainly recognized by natural IgG for innate protection, whereas PvE BP-RIII-V stimulates IgG production activity by B-cell for acquired immunity, and poses challenging questions to the selection of EBP.